Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release

BACKGROUND: A formulation of crush-resistant extended-release opioids may deter abuse. The purpose of this study was to evaluate the bioequivalence of oxymorphone extended-release (Oxy-ER) and a crush-resistant formulation of oxymorphone extended-release (Oxy-CRF). METHODS: In three open-label, rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedek, Irma H, Jobes, Janet, Xiang, Qinfang, Fiske, William D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232172/
https://www.ncbi.nlm.nih.gov/pubmed/22162639
http://dx.doi.org/10.2147/DDDT.S24372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232172/
https://www.ncbi.nlm.nih.gov/pubmed/22162639
http://dx.doi.org/10.2147/DDDT.S24372

Ejemplares similares